These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31718441)
1. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. Nguyen AB; Imamura T; Besser S; Rodgers D; Chung B; Raikhelkar J; Kalantari S; Smith B; Sarswat N; LaBuhn C; Jeevanandam V; Kim G; Sayer G; Uriel N J Am Heart Assoc; 2019 Nov; 8(22):e013278. PubMed ID: 31718441 [TBL] [Abstract][Full Text] [Related]
2. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768 [TBL] [Abstract][Full Text] [Related]
3. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure. Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786 [TBL] [Abstract][Full Text] [Related]
4. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement? Mohamedali B; Yost G; Bhat G Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796 [TBL] [Abstract][Full Text] [Related]
5. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience. Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856 [TBL] [Abstract][Full Text] [Related]
6. The Role of Thyroid Hormones in Heart Failure. Vale C; Neves JS; von Hafe M; Borges-Canha M; Leite-Moreira A Cardiovasc Drugs Ther; 2019 Apr; 33(2):179-188. PubMed ID: 30847626 [TBL] [Abstract][Full Text] [Related]
7. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation. Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353 [TBL] [Abstract][Full Text] [Related]
8. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device. Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450 [TBL] [Abstract][Full Text] [Related]
9. Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. Sugiura T; Kurihara C; Kawabori M; Critsinelis AC; Wang S; Civitello AB; Rosengart TK; Frazier OH; Morgan JA J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1083-1089.e1. PubMed ID: 30904255 [TBL] [Abstract][Full Text] [Related]
10. Mechanical circulatory support improves diabetic control in patients with advanced heart failure. Mohamedali B; Yost G; Bhat G Eur J Heart Fail; 2014 Oct; 16(10):1120-4. PubMed ID: 25298334 [TBL] [Abstract][Full Text] [Related]
11. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation. Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520 [TBL] [Abstract][Full Text] [Related]